X
11Nov

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Hogan Lovells | | Return|
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By: Hogan Lovells
Source Url: https://www.jdsupra.com/legalnews/covid-19-report-for-life-sciences-and-24214/

Related

Contractor Update: Do Employees Need To Carry Proof of Working for a Critical Sector Business?

Construction “of all kind” has been listed as a Critical Sector and exempt under the recent Stay a...

Read More >

Sustainable Development and Land Use Update - October 2020 #5

Governor Newsom pledges extra $200 million for homeless housing - Bullet The Mercury News – Octob...

Read More >

Standard to Determine FLSA Joint Employer Status Revised Under Department of Labor's Recently Adopted Final Rule

The Department of Labor (DOL) adopted a final rule on January 12, 2020, to revise and update its Par...

Read More >

Court Upholds Termination Of Employee Who Claimed Failed Drug Test Was Due to Over-the-Counter Medications

Seyfarth Synopsis: The Tenth Circuit Court of Appeals recently affirmed summary judgment in favor of...

Read More >

People Are Weird.

It's easier to lose your job if your replacement is a robot. In an interesting bit of industrial ps...

Read More >

Littler Global Guide - Italy - Q4 2019

Reserve Quotas for Disabled Employees and Mass Dismissals - Precedential Decision by Judiciary or R...

Read More >